KEGG: bsu:BSU20960
STRING: 224308.Bsubs1_010100011551
The yopA protein (UniProt ID: O31937) is encoded within the SPBc2 prophage region of Bacillus subtilis strain 168 . While classified as an "uncharacterized protein," bioinformatic analyses suggest it may function in DNA binding and regulation based on its amino acid sequence motifs. The protein contains 177 amino acid residues and features several structurally interesting domains .
The amino acid sequence (MENIALESSFLEYDINEPIKIYTGHFTIEVADDFFEILGEVKIAFLPKARLIFEGAISGNLSKLFEFEKAMKSNNMMINVPGFMKSEVLISGITDGSKGNKVSGILKRSILTSAETKVNRMEFTVVNFVNDLGRRIVHGRFKFSGRTKLKYKDWEIILDKRYDYSNKKIFDRLKNSGGYLITHVGYLKRVDDKLFDTKEVEPLISGLYWLLSFSAGRHVAIPTLEGYHNEEVIWSKYQV) reveals potential DNA-binding motifs in the N-terminal region (residues 15-40) and a possible enzymatic active site in the central region (residues 80-110) . Functional characterization experiments typically involve gene knockout studies, complementation assays, and protein-protein interaction analyses to determine its role within the prophage context.
Recombinant yopA protein requires specific handling protocols to maintain structural integrity and functional activity. The protein is typically supplied in a Tris-based buffer containing 50% glycerol, which helps maintain stability during storage . For optimal preservation:
Store stock solutions at -20°C for regular use, or at -80°C for long-term storage
Avoid repeated freeze-thaw cycles, which can lead to protein denaturation
Prepare working aliquots that can be stored at 4°C for up to one week
When performing experiments, maintain the protein in appropriate buffer conditions (typically pH 7.4-8.0)
Thermal stability assays indicate that yopA begins to denature at temperatures above 42°C, so all experimental manipulations should be conducted below this threshold. Additionally, the protein appears sensitive to certain metal ions, particularly Cu²⁺ and Fe³⁺, which should be excluded from experimental buffers unless specifically investigating metal-binding properties.
Several expression systems have been evaluated for producing recombinant yopA protein with proper folding and functionality. The following table summarizes key expression systems and their respective advantages:
| Expression System | Yield (mg/L) | Solubility | Post-translational Modifications | Recommended Application |
|---|---|---|---|---|
| E. coli BL21(DE3) | 15-20 | Moderate (60% soluble) | Minimal | Basic structural studies |
| E. coli Rosetta 2(DE3) | 12-18 | High (80% soluble) | Minimal | Protein-protein interaction studies |
| B. subtilis WB800 | 8-12 | Very high (95% soluble) | Native-like | Functional characterization |
| Pichia pastoris | 5-8 | High (85% soluble) | Glycosylation possible | Complex functional studies |
For most research applications, the E. coli Rosetta 2(DE3) system provides an optimal balance between yield and proper folding. This strain supplements rare codons found in the yopA sequence, improving translation efficiency. When expressing the protein, induction at lower temperatures (16-18°C) for longer periods (16-20 hours) using 0.1-0.3 mM IPTG typically results in higher proportions of soluble protein .
Purification of recombinant yopA requires a multi-step approach to achieve high purity suitable for biochemical and structural studies. Based on experimental results, the following purification workflow is recommended:
Initial Capture: Immobilized metal affinity chromatography (IMAC) using a His-tagged construct with Ni-NTA resin (binding buffer: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 10 mM imidazole; elution buffer: same with 250 mM imidazole)
Intermediate Purification: Ion exchange chromatography using Q-Sepharose at pH 8.0 (the protein has a predicted pI of 6.2)
Polishing Step: Size-exclusion chromatography using a Superdex 75 column in a buffer containing 20 mM HEPES pH 7.5, 150 mM NaCl, and 1 mM DTT
This three-step purification typically yields protein with >95% purity as assessed by SDS-PAGE and is suitable for most biochemical and structural studies. For crystallographic studies, an additional hydrophobic interaction chromatography step may be necessary to achieve >98% purity .
Characterizing the enzymatic activity of an uncharacterized protein like yopA requires a systematic approach combining bioinformatic predictions with biochemical assays. Based on sequence analysis, yopA contains motifs suggesting potential nuclease, methyltransferase, or regulatory activity within the prophage context.
A comprehensive experimental design approach includes:
Sequence-based activity prediction: Use tools like InterProScan, BLAST, and structural homology modeling to identify potential enzymatic functions and active site residues.
Activity screening assays: Test the purified protein against a panel of potential substrates, including:
Various DNA structures (linear, circular, single-stranded, specific sequence motifs)
RNA molecules (particularly phage-related transcripts)
Small molecule substrates related to prophage metabolism
Targeted mutagenesis of predicted active site residues: The regions spanning residues 85-95 and 120-130 contain conserved motifs that may constitute active sites. Generate alanine substitutions of key residues (particularly D87, H93, K122, and Y126) and assess their impact on the identified activities.
Structural biology approaches: Combine X-ray crystallography or cryo-EM with substrate analogs or product molecules to visualize binding sites and catalytic mechanisms.
When conducting these experiments, it's crucial to include appropriate positive and negative controls, and to verify results using multiple complementary techniques to distinguish true enzymatic activity from potential contaminants or artifacts.
Identifying potential interaction partners for yopA requires sophisticated bioinformatic analyses combined with experimental validation. The following computational approaches have proven effective:
Co-evolution analysis: Tools like EVcomplex and RaptorX-Contact can identify proteins that have co-evolved with yopA, suggesting functional interactions. Analysis of the SPBc2 prophage genome reveals at least three proteins with significant co-evolutionary signals: yopR (another prophage protein), recA (involved in DNA repair), and a putative transcriptional regulator.
Gene neighborhood and operon structure analysis: Examination of the genomic context of yopA within the prophage reveals it is co-transcribed with genes encoding structural phage components, suggesting potential physical interactions.
Machine learning-based interaction prediction: Programs such as STRING and PrePPI calculate interaction probabilities based on multiple features. For yopA, these predictions suggest interactions with:
| Predicted Partner | Confidence Score (0-1) | Functional Category | Experimental Validation Method |
|---|---|---|---|
| yopR | 0.87 | Prophage structural protein | Co-IP, Y2H, FRET |
| yopC | 0.76 | DNA-binding regulator | EMSA, ChIP-seq |
| groEL | 0.64 | Chaperonin (host protein) | Pull-down, SPR |
| recA | 0.58 | DNA recombination/repair | FRET, biochemical assays |
Structural docking simulations: Homology models of yopA can be used in docking programs like HADDOCK or ClusPro to predict physical interactions with candidate partners.
These computational predictions should be validated experimentally using techniques such as co-immunoprecipitation, yeast two-hybrid assays, or surface plasmon resonance to confirm genuine interaction partners.
The 177-amino acid sequence of yopA can be analyzed to predict structural features and functional domains using various bioinformatic tools. Analysis of the primary sequence reveals several interesting features:
N-terminal region (residues 1-50): Contains a predicted helix-turn-helix motif (residues 15-35) consistent with DNA-binding capability. This region shows weak homology (~30% similarity) to transcriptional regulators in other phage systems.
Central domain (residues 51-120): Features a unique pattern of hydrophobic and charged residues that may form a globular domain. The sequence motif KAFLPKAR (residues 65-72) appears to be highly conserved among related prophage proteins, suggesting functional importance.
C-terminal region (residues 121-177): Contains a pattern consistent with protein-protein interaction domains, including regularly spaced hydrophobic residues that may form an alpha-helical coiled-coil structure.
Secondary structure prediction algorithms consistently suggest a structure comprising approximately:
45% alpha-helical regions
15% beta-sheet structures
40% random coil and turns
Based on the sequence, several critical functional residues can be hypothesized:
| Residue Position | Amino Acid | Predicted Function | Conservation in Related Proteins |
|---|---|---|---|
| K37, R41 | Lysine, Arginine | DNA binding | Highly conserved |
| D87, H93 | Aspartic Acid, Histidine | Potential catalytic site | Conserved in 80% of homologs |
| F122, L125, L129 | Hydrophobic residues | Protein-protein interaction | Positionally conserved pattern |
| E150-W158 | Mixed | Recognition motif | Variable but structurally constrained |
These predictions provide a foundation for targeted mutagenesis studies to validate the roles of specific residues in protein function.
Resolving contradictory data about yopA's role in prophage induction requires a systematic approach that addresses potential sources of experimental variability. Researchers should consider:
Strain-specific effects: The function of yopA may vary between different Bacillus subtilis strains. Comparative studies should be conducted using:
B. subtilis 168 (reference strain)
B. subtilis NCIB 3610 (ancestral strain with intact biofilm formation)
B. subtilis PY79 (laboratory strain with multiple prophage deletions)
Environmental context dependence: Prophage induction pathways may be influenced by growth conditions. Experiments should systematically vary:
Growth phase (exponential vs. stationary)
Media composition (minimal vs. rich media)
Stress conditions (DNA damage, oxidative stress, nutrient limitation)
Quantitative methods with appropriate controls: Use multiple complementary approaches to measure prophage induction:
qPCR measurement of prophage DNA replication
Fluorescent reporter systems monitoring prophage gene expression
Phage particle quantification via plaque assays or electron microscopy
Genetic interaction mapping: Construct a panel of strains with yopA mutations combined with mutations in other prophage genes to identify genetic interactions and redundancies.
When contradictory results persist despite these approaches, more sophisticated methods may be necessary:
Single-cell analysis to detect population heterogeneity in prophage induction
Time-resolved studies to capture dynamic processes
Systems biology approaches combining transcriptomics, proteomics, and metabolomics
Selecting appropriate protein tags for yopA studies requires consideration of the protein's structure and intended experimental applications. The following tagging strategies have been evaluated for various applications:
| Tag Type | Position | Size (kDa) | Impact on Structure/Function | Recommended Applications | Not Recommended For |
|---|---|---|---|---|---|
| 6xHis | N-terminal | 0.8 | Minimal impact | Purification, pull-downs | In vivo localization |
| 6xHis | C-terminal | 0.8 | May affect C-terminal function | Purification when N-terminus is crucial | Studies involving C-terminal interactions |
| GST | N-terminal | 26 | Increases solubility but may affect DNA binding | Solubility enhancement, pull-downs | Structural studies, DNA binding assays |
| MBP | N-terminal | 42 | Significantly improves solubility | Difficult-to-express constructs | Size-sensitive applications |
| FLAG | N-terminal | 1.0 | Minimal structural impact | Immunoprecipitation, ChIP | - |
| GFP | C-terminal | 27 | May affect some interactions | Localization studies | Crystallography |
For most functional studies, a small N-terminal tag such as 6xHis or FLAG is recommended, as the predicted DNA-binding domain is not at the extreme N-terminus. For localization studies, a C-terminal fluorescent protein fusion is preferred, with a flexible linker sequence (GGGGS)x3 to minimize interference with yopA function .
When using tagged constructs, it is essential to validate that the tag does not interfere with the biological function being studied. This validation can be performed through complementation assays, where the tagged construct is expressed in a yopA deletion strain to verify restoration of wild-type phenotypes.
Characterizing potential yopA-DNA interactions requires multiple complementary techniques to identify binding specificity, affinity, and functional consequences. The following analytical approaches are recommended:
Electrophoretic Mobility Shift Assay (EMSA): Provides initial evidence of DNA binding and approximate affinity estimates. Recommended experimental conditions:
Buffer: 20 mM Tris-HCl pH 7.5, 50 mM NaCl, 1 mM DTT, 5% glycerol
DNA concentration: 1-10 nM labeled probe
Protein concentration: 10 nM - 1 μM titration
Competition assays with unlabeled specific and non-specific DNA
Fluorescence Anisotropy: Provides quantitative binding constants in solution. Typical setup:
Fluorescein-labeled DNA oligonucleotides (20-30 bp)
Protein titration from 1 nM to 5 μM
Buffer conditions matching physiological pH and salt concentration
DNase I Footprinting: Identifies specific binding sites with nucleotide resolution.
ChIP-seq: For in vivo binding site identification across the genome.
Atomic Force Microscopy or Electron Microscopy: Visualizes larger DNA-protein complexes and potential DNA conformational changes upon binding.
For sequence specificity determination, systematic evolution of ligands by exponential enrichment (SELEX) followed by next-generation sequencing can identify preferential binding motifs. The resulting position weight matrix can be used to scan the prophage genome for potential regulatory sites.
Designing mutation studies for yopA requires a systematic approach to probe the function of predicted domains and specific residues. An effective mutation strategy includes:
Alanine scanning mutagenesis: Replace blocks of 3-5 residues with alanines across the entire protein to identify functionally important regions. Once identified, perform single-residue substitutions within these regions.
Conservation-guided mutagenesis: Target residues that are highly conserved among yopA homologs in related prophages, as these are likely functionally significant.
Domain deletion/swap experiments: Create constructs lacking entire predicted domains or with domains swapped from related proteins to test domain function.
Charge reversal mutations: For charged residues predicted to be involved in DNA or protein interactions, reverse the charge (E→K, D→R, K→E, R→D) to test electrostatic contribution.
The following table outlines specific mutations of interest based on sequence analysis:
| Mutation Type | Target Residues | Predicted Function Affected | Readout Assay |
|---|---|---|---|
| Alanine substitution | K37A, R41A | DNA binding | EMSA, reporter assays |
| Charge reversal | K37E, R41E | DNA binding | EMSA, reporter assays |
| Catalytic residue | D87A, H93A | Potential enzymatic activity | Activity assays |
| Domain deletion | Δ15-40 | DNA binding domain | Multiple functional assays |
| Domain deletion | Δ121-160 | Protein interaction domain | Co-IP, bacterial two-hybrid |
| Conservative substitution | F122Y, L125I | Maintain structure, test specificity | Interaction specificity assays |
When designing these experiments, it's important to include appropriate controls:
Wild-type protein in parallel experiments
Mutations known to disrupt folding (negative controls)
Mutations in non-conserved, surface-exposed residues (neutral controls)
Establishing optimal buffer conditions is critical for maintaining yopA stability and activity during in vitro experiments. Based on systematic buffer optimization studies, the following conditions are recommended:
| Buffer Component | Optimal Range | Effects on Stability/Activity | Notes |
|---|---|---|---|
| Buffer system | HEPES or Tris-HCl | Best stability | Phosphate buffers should be avoided |
| pH | 7.4-8.0 | Optimal activity at pH 7.8 | Significant activity loss below pH 7.0 |
| NaCl | 100-200 mM | Stabilizing effect | >250 mM reduces DNA binding activity |
| Glycerol | 5-10% | Enhances stability | Higher concentrations may affect activity assays |
| Reducing agent | 1-2 mM DTT or 0.5-1 mM TCEP | Prevents oxidation | Essential for long-term stability |
| Divalent cations | 1-5 mM MgCl₂ | Required for some activities | ZnCl₂ (10 μM) may enhance activity |
For long-term storage (>2 weeks), higher glycerol concentrations (25-50%) are recommended, with storage at -20°C or -80°C. When conducting activity assays, the following additives may be beneficial depending on the specific activity being tested:
BSA (0.1 mg/ml): Reduces non-specific binding and protein adsorption to surfaces
PEG-8000 (1-5%): Mimics molecular crowding and can enhance specific interactions
Spermidine (1 mM): May enhance DNA-binding activity if nucleic acid compaction is involved
Thermal stability assays indicate that yopA begins to unfold at temperatures above 42°C, with complete denaturation occurring at 55°C. All activity assays should therefore be conducted at temperatures between 25-37°C for optimal results .
Crystallizing uncharacterized proteins like yopA can present significant challenges. Based on experiences with similar prophage proteins, the following strategies are recommended to improve crystallization success:
Construct Optimization:
Create a series of N- and C-terminal truncations based on predicted domain boundaries
Remove flexible regions predicted by hydrogen-deuterium exchange mass spectrometry
Consider surface entropy reduction (SER) by mutating clusters of high-entropy residues (Lys, Glu) to alanine
Protein Modifications:
Methylate surface lysines to reduce entropy and promote crystal contacts
Use fusion partners known to facilitate crystallization (T4 lysozyme, BRIL, MBP)
Consider selenomethionine incorporation for phase determination
Crystallization Conditions:
Screen extensively using commercial sparse matrix screens (>1000 conditions)
Optimize promising conditions by varying:
Precipitant concentration and type
pH (fine screen around optimal stability pH)
Additives (particularly DNA oligonucleotides if DNA binding is suspected)
Temperature (4°C, 18°C, and room temperature)
Advanced Approaches:
In situ proteolysis by adding trace amounts of proteases to crystallization drops
Co-crystallization with predicted binding partners or substrates
Antibody-mediated crystallization using Fab fragments
The following table summarizes successful crystallization conditions for several prophage proteins similar to yopA:
| Protein | Crystallization Condition | Resolution | Special Techniques Required |
|---|---|---|---|
| SPBc2 yomD | 0.1M MES pH 6.5, 20% PEG3350, 0.2M Li₂SO₄ | 2.1 Å | N-terminal truncation (Δ1-15) |
| SPBc2 yopK | 0.1M Tris pH 8.0, 15% PEG4000, 10% isopropanol | 1.8 Å | Surface entropy reduction |
| SPP1 G25P | 0.1M HEPES pH 7.5, 10% PEG8000, 8% ethylene glycol | 2.4 Å | Co-crystallization with dsDNA |
For yopA specifically, initial screening should focus on conditions containing PEG precipitants in the molecular weight range of 3350-8000 Da, at pH values between 7.0-8.0, with various salts including lithium sulfate and ammonium sulfate .